Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations. (2013)
Attributed to:
MICA: MRC Centre for Neuromuscular Diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.nmd.2012.11.004
PubMed Identifier: 23219351
Publication URI: http://europepmc.org/abstract/MED/23219351
Type: Journal Article/Review
Volume: 23
Parent Publication: Neuromuscular disorders : NMD
Issue: 2
ISSN: 0960-8966